These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2969629)

  • 1. Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.
    Markwalder TM; Gerber HA; Waelti E; Schaffner T; Markwalder RV
    Surg Neurol; 1988 Aug; 30(2):97-101. PubMed ID: 2969629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
    Waelti ER; Markwalder TM
    Surg Neurol; 1989 Feb; 31(2):96-100. PubMed ID: 2522246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
    Markwalder TM; Waelti E; König MP
    Surg Neurol; 1987 Jul; 28(1):3-9. PubMed ID: 2954242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
    Jääskeläinen J; Laasonen E; Kärkkäinen J; Haltia M; Troupp H
    Acta Neurochir (Wien); 1986; 80(1-2):35-41. PubMed ID: 2939693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
    Altinoz MA; Ozpinar A; Elmaci I
    Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, Forskolin and phorbol ester in vitro.
    Koehorst SG; Spapens ME; Van Der Kallen CJ; Van 'T Verlaat JW; Blaauw G; Thijssen JH; Blankenstein MA
    Int J Biol Markers; 1998; 13(1):16-23. PubMed ID: 9681295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression.
    Nagashima G; Asai J; Suzuki R; Fujimoto T
    Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical evidence of progesterone receptors in human meningiomas.
    Waelti ER; Markwalder TM
    Surg Neurol; 1989 Mar; 31(3):172-6. PubMed ID: 2922658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
    Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
    J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Cancer; 1990 Mar; 65(6):1375-9. PubMed ID: 2137722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors in meningiomas.
    Cahill DW; Bashirelahi N; Solomon LW; Dalton T; Salcman M; Ducker TB
    J Neurosurg; 1984 May; 60(5):985-93. PubMed ID: 6716168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor expression and Ki-67 labelling index of meningiomas in the Lagos university teaching hospital.
    Ikeri NZ; Anunobi CC; Bankole OB
    Niger Postgrad Med J; 2018; 25(1):17-20. PubMed ID: 29676340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous estradiol and progesterone receptor analysis in meningiomas.
    Lesch KP; Fahlbusch R
    Surg Neurol; 1986 Sep; 26(3):257-63. PubMed ID: 3738720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.